Professor Shuye Wang: Emphasizing early diagnosis and treatment of systemic amyloidosis to improve patient cure rates | 2024 CSCO Hematology Academic
Due to its low incidence and diverse clinical manifestations, patients with AL amyloidosis are often misdiagnosed or underdiagnosed, resulting in insufficient treatment. From January 26th to 28th, 2024, the "China Society of Clinical Oncology (CSCO) Leukemia Expert Committee, Lymphoma Expert Committee, and Myeloma Preparatory Committee Working Meeting, and the 2024 CSCO Hematology, Lymphoma, and Myeloma Disease Academic Conference" was successfully held in Haikou. During the conference, Professor Shuye Wang from the First Affiliated Hospital of Harbin Medical University shared insights with Oncology Frontier - Hematology Frontier on the current status of diagnosis and treatment of systemic amyloidosis, perspectives on early diagnosis, and the future research plans of his team.